MicroBioLogics, Inc. Appoints New President
Brad Goskowicz has been named President of MicroBioLogics, Inc., a global leader in producing biological reference material for Quality Control testing. Previously, Brad served as the Chief Marketing Officer for the company.
MicroBioLogics was founded in 1971 as a laboratory testing facility specializing in environmental and public health threats. Today, the company is a leading manufacturer of lyophilized microorganism preparations for Quality Control testing in the Clinical, Pharmaceutical, Cosmetic, Food Quality, Educational, Water and Environmental Industries. There are currently more than 130 authorized MicroBioLogics Distributors serving approximately 120 countries around the world.
Brad Goskowicz joined MicroBioLogics in February of 2009 as the Chief Marketing Officer. Previously, Brad served in senior sales, marketing, and leadership positions with companies such as Johnson & Johnson, Medtronic, Thoratec, and Myocor. In addition, Brad has served as President of US Speedskating for the last four years. Since joining MicroBioLogics, he has led the market launch of EZ-Accu Shot and other key marketing initiatives.
In his new role, Brad will be executing and overseeing the company's strategic business plan. Brad comments, "I'm honored to be named President of MicroBioLogics. The company is unique in the marketplace and there are many opportunities for growth. We look forward to leading the way to a healthier, safer world by continuing to develop new and innovative methods of providing key biomaterials around the world."
MicroBioLogics is majority owned by St. Cloud, Minnesota based Granite Equity Partners. Granite Equity Partners invests human and financial capital from its community of investors, executives, and advisors to advance select companies toward their full potential.
About MicroBioLogics, Inc.
MicroBioLogics manufactures cost-effective, reliable, and convenient biological reference materials for Quality Control in microbiology labs. They specialize in manufacturing lyophilized microorganisms for clinical, pharmaceutical, cosmetic, food quality, educational, water and environmental laboratories. The company is ISO 9001:2008 certified and is accredited in accordance with ISO 17025:2005 and ISO Guide 34:2000. Additionally, MicroBioLogics has achieved FDA registration and CE Mark conformity. Currently, MicroBioLogics has an international distribution network of 130 companies and ships to approximately 120 countries around the world.
About Granite Equity Partners:
Granite Equity Partners is a private equity firm headquartered in St. Cloud, Minnesota. They specialize in financing buyouts, recapitalizations, and growth company transactions which include the sale or purchase of a business, generational transfers, or business expansions. The partners are a diverse group of experienced professionals who are committed to the success of the companies they invest in. For more information, visit www.graniteequity.com
SOURCE: MicroBioLogics, Inc.